On August 20, 2026, Dallah Healthcare Company announced that its Board of Directors approved the resignation of Dr. Ahmed bin Saleh Babaeer from his position as Chief Executive Officer and his membership on the Investment and Finance Committee, citing personal circumstances, with the resignation taking effect on September 1, 2026. In his place, Eng. Muteab bin Abdullah Altukeas has been appointed as Acting Chief Executive Officer and member of the Investment and Financing Committee, effective the same date. Eng. Altukeas holds a Master's degree in Project Management from Heriot-Watt University and a Bachelor's degree in Civil Engineering from King Saud University, with over 15 years of experience in strategy, project management, and mergers and acquisitions, having previously served as Chief Strategy Officer at Dallah Healthcare Company since 2022.

Original announcement:

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.